AKT1 and type 2 diabetes mellitus: Its anti-diabetic effects have also been demonstrated in T2DM (db/db) mouse models, and it promoted glycogen synthesis by activating PI3K/AKT/GSK-3β signaling pathway in liver tissue (Sun et al., 2017).